Literature DB >> 2653044

Timolol-pilocarpine combined vs timolol and pilocarpine given separately.

M B Söderström1, O Wallin, P A Granström, W Thorburn.   

Abstract

In a controlled, double-observer, multicenter study, we compared the effect of a fixed combination of timolol 0.5%-pilocarpine 4% twice a day with that of timolol 0.5% twice a day plus pilocarpine 4% three times a day in 80 patients with open-angle glaucoma whose intraocular pressure was greater than 21 mm Hg on timolol 0.5% twice a day alone. Administered twice daily, the combination drug lowered intraocular pressure as effectively as concomitant treatment with timolol twice a day and pilocarpine three times a day. No statistically significant differences in reduction of intraocular pressure were found between the two groups nor were any unexpected side effects observed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2653044     DOI: 10.1016/0002-9394(89)90489-3

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  3 in total

1.  Comparison of the intraocular pressure lowering effect of latanoprost and a fixed combination of timolol-pilocarpine eye drops in patients insufficiently controlled with beta adrenergic antagonists. French Latanoprost Study Group, and the Swedish Latanoprost Study Group.

Authors:  J P Nordmann; M Söderström; J F Rouland; F Malecaze
Journal:  Br J Ophthalmol       Date:  2000-02       Impact factor: 4.638

2.  Intraocular pressure rise after phacoemulsification with posterior chamber lens implantation: effect of prophylactic medication, wound closure, and surgeon's experience.

Authors:  T G Bömer; W D Lagrèze; J Funk
Journal:  Br J Ophthalmol       Date:  1995-09       Impact factor: 4.638

3.  Ocular hypotensive efficacy and safety of a combined formulation of betaxolol and pilocarpine.

Authors:  A L Robin
Journal:  Trans Am Ophthalmol Soc       Date:  1996
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.